Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients

Rebecca Evans, Emmanuel Mignot, Robert Alexander et al.|Proceedings of the National Academy of Sciences|2022

Cited by 92